Akari Therapeutics Plc
AKTXNasdaqCIK 1541157HealthcareFiscal year ends Dec 31
Reports and events: 308 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-3016:45 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-049446 |
| 2026-10-0117:00 ET | DEF 14A | Proxy statementPeriod 2026-10-01 | 0001493152-26-045371 |
| 2026-10-0116:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-045364 |
| 2026-08-1316:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-037736 |
| 2026-08-1316:00 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-037730 |
| 2026-07-0217:25 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-031972 |
| 2026-06-2617:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-030341 |
| 2026-06-2617:00 ET | S-1/A | Registration statement, amended | 0001493152-26-030330 |
| 2026-06-0416:30 ET | DEF 14A | Proxy statementPeriod 2026-06-04 | 0001493152-26-027279 |
| 2026-05-2216:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-025037 |
| 2026-05-1917:00 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-024446 |
| 2026-05-0817:08 ET | S-1 | Registration statement | 0001493152-26-022019 |
| 2026-03-3017:39 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-013664 |
| 2026-03-1717:07 ET | 8-K | 3.03 Change to security holders’ rights; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-010602 |
| 2026-03-0416:52 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001493152-26-008880 |
| 2026-03-0416:44 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001493152-26-008874 |
| 2026-03-0217:00 ET | 8-K | 5.07 Shareholder vote results | 0001493152-26-008570 |
| 2026-02-0211:15 ET | DEF 14A | Proxy statementPeriod 2026-02-02 | 0001493152-26-004754 |
| 2026-01-2317:17 ET | S-1 | Registration statement | 0001493152-26-003458 |
| 2025-12-1710:15 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-028075 |
| 2025-12-1616:30 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-25-027969 |
| 2025-12-0808:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-026533 |
| 2025-11-2617:00 ET | 8-K | 3.01 Delisting notice | 0001493152-25-025177 |
| 2025-11-1717:00 ET | DEF 14A | Proxy statementPeriod 2025-11-17 | 0001493152-25-023911 |
| 2025-11-1716:56 ET | S-1 | Registration statement | 0001493152-25-023908 |
| 2025-11-1317:01 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-022390 |
| 2025-10-2316:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-25-019112 |
| 2025-10-1609:20 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-018269 |
| 2025-10-1508:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-018091 |
| 2025-09-2917:00 ET | 8-K | 8.01 Other events | 0001493152-25-016039 |
| 2025-09-2517:00 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-014962 |
| 2025-08-2917:15 ET | S-1 | Registration statement | 0001641172-25-026052 |
| 2025-08-2917:01 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001641172-25-026032 |
| 2025-08-2117:00 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001641172-25-025104 |
| 2025-08-1908:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-024732 |
| 2025-08-1317:01 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001641172-25-023569 |
| 2025-07-0117:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-092350 |
| 2025-06-0616:05 ET | DEF 14A | Proxy statementPeriod 2025-06-06 | 0001641172-25-014023 |
| 2025-05-1508:58 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-072046 |
| 2025-05-1416:51 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-071563 |
| 2025-04-1608:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-054484 |
| 2025-04-1516:33 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-054278 |
| 2025-03-2008:50 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-042342 |
| 2025-03-0309:10 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-043544 |
| 2025-02-1417:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-021393 |
| 2025-01-1308:00 ET | 8-K | 7.01 Regulation FD disclosure | 0000950170-25-004576 |
| 2024-12-1816:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-137922 |
| 2024-12-1616:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-136674 |
| 2024-12-1216:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-135822 |
| 2024-12-0616:00 ET | SC 13D/A | Ownership report, active investor, amended | 0001213900-24-106465 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 17:09 ET. Listed shows no prices and gives no investment advice.